UK house prices rise in ‘Spring bump’

A ‘Spring Bump’ has lifted UK house prices for a second month in a row, according to new data from Halifax. The average UK house price crept up 0.8% month-on-month in March, following a 1.2% increase in February.

Halifax noted price rises in all UK regions in March.

“The spring bump has brought a second month of rising house prices, and a whiff of optimism to the housing market,” said Sarah Coles, head of personal finance, Hargreaves Lansdown.

Despite rises in February and March, UK house prices are down 2% from their peak in August.

“Overall these latest figures continue to suggest relative stability in the housing market at the start of 2023 and align with many other recent industry surveys and data, said Kim Kinnaird, Director, Halifax Mortgages.

“This has been characterised by a partial recovery in activity and transactions, especially when compared to the significant drops seen at the end of last year, with latest Bank of England data showing mortgage approvals rising for the first time in six months.”

The average UK house price is now £287,880, compared to £285,660 in February.

Aura Renewable Acquisitions cash discount

0

Aura Renewable Acquisitions (LON: ARA) got off to a strong start when trading in the shares commenced in April 2022, with the share price peaking at 17p, but it has fallen below the 10p placing price.

At the end of 2022, there was still £809,000 in cash following a £236,000 loss – mainly down to the expenses of the flotation. That means there is around 8p a share in cash, while the share price is 4.75p (4.5p/5p). There is a two-fifths discount to cash, plus there is a value to the listing as well.

One year after joining the standard list cash shell Aura Renewable Acquisitions is still considering its first acquisition. The directors are not taking any fees and the expenses are minimal, although some cash may be required for investigating potential acquisitions.

Any acquisition would have to have a sustainable and growing business with a management that would continue to be involved after the reversal. The directors are not looking for start-ups.

The prospectus did not narrow down the potential renewable industries that Aura Renewable Acquisitions could become involved in. It listed a wide range.

It appears most likely that the acquisition will be involved in the battery, solar or wind sectors, but other activities are not ruled out. There is no specific geographical focus, although the board has experience in Europe and the purchase, wherever it is based, would ideally have potential for growth in Europe.

The board includes David Fitzsimmons who was boss of Novera Energy, which joined AIM in June 2005 at 53p a share. Novera had landfill gas, hydro and wind assets. At the end of 2009, Novera was acquired by Infinis Energy for 77p a share, valuing the company at £111.7m.

The timing of any deal is difficult to predict, as is what business it will be, but if investors are interested in exposure to the renewables sector and want to take a risk on that then this is a good time to consider buying the shares – as long as there are any available.

Tax changes for the 2023/2024 tax year

The new tax year has ushered in a series of changes to tax including capital gains tax, dividends and early stage investment schemes such as the Seed Enterprise Investment Scheme.

The tax changes will have implications for investors who will have to considered them carefully when managing their portfolios. The below summary is by no means exhaustive.

Capital Gains Tax

Capital gains tax is changing and will continue to continue to change in subsequent tax years.

In the new tax year starting April 2023, the Capital Gains Tax annual allowance will reduce to £6,000 from £12,300.

In 2024, this will fall further to £3,000 from April 2024.

Seed Enterprise Investment Scheme (SEIS)

SEIS is a generous tax incentive to facilitate investment by private individuals into start ups at their earliest stage. Tax benefits for investors include 50% income tax relief on the amount invested, exemption from capital gains on disposal, and loss relief.

The annual amount an investor can invest through the SEIS scheme will double from £100,000 to £200,000.

In addition, companies can now raise £250,000, up from £150,000 previously. Rules on the type of companies able to raise funds through SEIS will also change.

Companies that have been trading for less than three years can now utilise the scheme, an expansion from those trading for less than two years previously. Gross assets allowable to qualify for SEIS will be increased to £350,000.

EIS rules will stay the same.

Income Tax

The Basic rate tax band of 20% will remain at £37,700 in the 2023/24 tax year. The higher tax rate of 40% will be applied to £125,140, this is down from £150,000. The additional tax rate of 45% will apply to all earnings above £125,140.

Dividend tax rates

The dividend allowance will fall to £1,000 in 2023/24, down from £2,000 in 2022/23. This is set to fall further to £500 in the next tax year.

After the dividend allowance, dividends will be taxed as follows:

2022/232023/24
Basic rate8.75%8.75%
Higher rate33.75%33.75%
Additional rate39.35%39.35%

Defensive stocks drive FTSE 100 higher

Defensive stocks provided the FTSE 100’s upside support on Wednesday as investors rotated into equities that tend to do better during economic downturns.

The FTSE 100 was 0.45% higher at 7,670 at the time of writing.

The recent mini banking crisis diverted attention from the underlying health of the global economy – and presented investors with a range of bargains in the aftermath.

Now the FTSE 100 has rebounded from the lows, markets will become increasingly conscious of the economic outlook and ramifications for company earnings. 

OPEC’s move this week to cut production adds to uncertainty. “Clearly, it’s not a positive for global growth,” said Janet Yellen, US Treasury Secretary.

The cut in production risks higher inflation and the possibility of higher interest rates. This could derail the global economy.

“The concern is the Federal Reserve might have to sound the retreat before its war on inflation is truly done. This could leave us with the worst of all worlds – the dreaded stagflation where the economy is shrinking but prices are continuing to surge higher,” said AJ Bell head of financial analysis Danni Hewson.

In preparation for the possibility of choppier times ahead in markets, investors bought into UK-listed utilities, precious metals and pharmaceuticals on Wednesday.

United Utilities was the top gainer at the time of writing, up over 3%. There was also interest in Severn Trent in Centrica, both of which added more than 2%.

AstraZeneca was up around 2% and added a significant number of points to the index due their large market capitalisation.

The rotation away from cyclical stocks was clear. Housebuilding, mining and retail stocks were all in the red.

AIM movers: Fulham Shore bid and Drumz reversal

0

Restaurants operator Fulham Shore (LON: FUL) is recommending a 14.15p a share cash bid by Tokyo-based TORIDOLL Holdings. The share price jumped 32.4% to 13.9p. The bidder has revenues of around £1bn and already has European interests. It works with specialist private equity firm Capdesia in Europe. The takeover will enable greater expansion of the Franco Manca and The Real Greek brands.

Building products and services provider Northern Bear (LON: NTBR) is paying a 4p a share dividend plus an additional 1p a share special dividend. A semi-annual dividend is promised and management says that it plans a higher investor relations profile. The share price is 25.7% higher at 46.5p. Underlying trading has been ahead of expectations, although there will be a provision of up to £750,000 for unprofitable contracts taken on by Northern Bear Building Services. Underlying 2022-23 operating profit should exceed £2.75m.

ScotGold Resources (LON: SGZ) has secured short-term financing for the Cononish gold and silver mine. The gold offtake provider has advanced $500,000 with payment against monthly deliveries from July to November. Debt provider Bridge Barn, which is controlled by non-exec Nathaniel le Roux, is deferring $450,000 of interest payments until 1 December. This gives ScotGold Resources the opportunity to change its mining plans so that gold production is enhanced. The share price recovered by one-fifth to 15p.

Crimson Tide (LON: TIDE) has won an initial flagship contract with an NHS Trust in south east England worth £250,000 over 36 months. The mpro5 Smart App will capture and consolidate incident and response data. This contract can be expanded as more IoT sensors across the trust. The share price rose 11.8% to 2.85p.

Oxford BioDynamics (LON: OBD) plans to launch prostrate screening EpiSwitch test in the UK and US by the end of 2023. The main EpiSwitch CiRT test to identify patients that will benefit for the checkpoint inhibitor class of cancer immunotherapies is building sales in the US. US lab space has been leased for a CLIA-certified testing facility. The share price increased by 7.46% to 15.85p.

Acuity Risk Management is reversing into Drumz (LON: DRUM) and the enlarged group is changing its name to Acuity RM. A share issue will raise £1.45m – £950,000 after expenses – at 4.5p a share. The share price slipped 11.1% to 0.6p. Drumz already owns 25% of Acuity Risk Management. The reversal should be completed on 25 April. Drumz other investment is a 5.85% stake in KCR Residential REIT (LON: KCR) and the shares are unchanged at 9.5p.

Franchise Brands (LON: FRAN) shares continue to fall and are down a further 3.55% to 176.5p, which is below the 180p placing price when £92m was raised to help finance the acquisition of Pirtek Europe.

Shield Therapeutics (LON: STX) has appointed Andy Hurley as chief commercial officer and he will head the US push for the company’s Accrufer iron deficiency treatment. The full US sales team should be hire by 1 May. The share price declined by 3.28% to 5.9p.

RS Group shares sink as revenue growth stutters

RS Group, formerly know as Electrocomponets, released their trading statement for the fourth quarter ended March 2023 on Wednesday. The update revealed slowing revenue growth across the group, but the company were confident profit for the year would exceed expectations.

RS Group has a broad product range including electrical and testing equipment, and lines of semiconductors and microprocessors.

All three of their geographies experienced slowing revenue growth in Q4 with sales contracting in the Americas (-4%) and Asia Pacific (-15%) regions. EMEA like-for-like revenue growth slowed to 6% from 12% in Q3. Group revenue grew just 1% in Q4.

RS attributed the poor performance in Asia to Chinese lockdowns and ongoing geopolitical issues, as well as problems in the semi conductor supply chain.

Despite slowing revenue figures, RS Group said they expected operating profit for the year to be ahead of expectations as margin improved slightly.

“Effective execution and the ongoing hard work, enthusiasm and passion of our people has led to a very strong performance in 2022/23 and we anticipate full year adjusted operating profit to be slightly ahead of consensus expectations,” said David Ega, RS Group Chief Financial Officer.

Investors did not share their enthusiasm and passion on Wednesday and shares in the group were down over 4% at the time of writing.

Why companies left AIM in March 2023

There were four companies that left AIM during March with only one new admission – Onward Opportunities (LON: ONWD) - to replace them. Two of the companies were taken over, while one sold its business ahead of winding-up and the other changed its strategy, deciding to focus on an ASX listing.
1 March 2023
Appreciate Group
Corporate and consumer redemption products provider Appreciate (LON: APP) was acquired by PayPoint (LON: PAY) in a deal that valued the prepaid vouchers and Christmas savings group at £83m – based on a PayPoint share price of 580p. The offer was 33p in cash and 0.019 of a Pay...

New AIM admission: Ocean Harvest Technology

Ocean Harvest Technology makes seaweed-based ingredients for animal feed. These are used by animal feed producers as part of the mix that goes into the production. They use the ingredients because studies indicate that they can improve health and yields.
Management believes it has spent €20m on developing and commercialising these ingredient products. The cash raised will finance additional marketing, increase manufacturing capacity and enable further product development.
The share price opened at 17p and ended the first day of trading at 17.125p (16.25p/18p). There were 3.25 million shares tr...

Saga shares sink as losses accelerate

Saga’s IPO at a £2.1 billion valuation seemed a long time ago on Tuesday morning as the company shed another 10% following the release of the group\s preliminary results for the year ending 31st January 2023.

Losses before tax accelerated to £254m from £24m a year prior as a £269m impairment charge to their insurance business destroyed modest underlying profit before tax.

Although, revenue for the year increased to £581.1m from £377.2m as a result of travel bookings bouncing back, concerns about the economic backdrop and insurance business did little to spark optimism among investors.

“Over the past year, through what continued to be a particularly challenging external backdrop, Saga made progress against its strategy while achieving significant revenue growth and returning to underlying profit,” said Euan Sutherland, Saga’s Group Chief Executive Officer.

Underlying profit before tax rose to £21.5m from a £6.7m loss last year.

“The longer the market had to look at Saga’s results this morning the less it liked about them. Yes, in theory the group returned to ‘profit’. But this was an adjusted profit and on a statutory basis losses widened thanks to impairments on its insurance business,” said Danni Hewson, head of financial analysis at AJ Bell.

Hewson continued to explain two big problem’s at Saga – lower cash flow and a big debt pile.

“And cash flow, the one metric which is difficult to massage, was materially lower year-on-year with only a modest reduction in the company’s onerous debt pile.

“Guidance for the insurance business was gloomy and Saga has very little credit in the bank with long-suffering shareholders as it looks to turn around the business.

“In theory Saga’s proposition makes sense. The over-50s are a growing and relatively wealthy demographic who, if they own their homes outright, are less exposed to the recent increases in interest rates.”

Hewson concluded with a damning assessment of Saga time as a listed company:

“However, Saga has never delivered on the promise which accompanied its market listing nine years ago. A series of operational failures have tripped the company up and damaged its credibility.”

Likewise adds to market share

0

Floorcoverings distributor Likewise Group (LON: LIKE) continues to gain share in a tough market. First quarter revenues were 19.7% higher as investment in capacity continues to pay off for the number two in the UK flooring distribution market.  

Last April’s acquisition Delta Carpets was not included in the comparative period, but it is not a big business. Higher prices helped but there was significant underlying growth.

The estimated 2022 revenues doubled to £124.4m. Zeus forecasts a 10% improvement in 2023 revenues to £136.6m, so this is a good start to the year. There is still uncertainty about consumer spending, though, and the first quarter is a limited guide to the full year.

Flat pre-tax profit of £2.5m is forecast for 2023. However, operational gearing means that if revenues continue to beat expectations the profit figure could be much higher.

AIM-quoted Likewise has an estimated market share of 7%. The current focus is organic growth, although acquisitions are still possible at the right price. There are still deferred payments for past acquisitions, but capital investment will ease from next year. Cash generation will improve, and net debt will be minimal, which means there will be finance available for deals.

The 2022 results will be published on 16 May. At 21p, the shares are trading on 21 times prospective 2023 earnings.